Author of the publication

MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain

, , , , , and . Vaccine, 23 (17-18): 2191--6 (March 2005)PMID: 15755593.
DOI: S0264-410X(05)00069-1

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Immunogenicity, Reactogenicity, and Safety of a P1.7b,4 Strain-Specific Serogroup B Meningococcal Vaccine Given to Preteens, , , , , , , , , and 3 other author(s). Clinical and Vaccine Immunology : CVI, 14 (11): 1393–9 (November 2007)PMC2168176.MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain, , , , , and . Vaccine, 23 (17-18): 2191--6 (March 2005)PMID: 15755593.A prospective study of the effectiveness of the New Zealand meningococcal B vaccine, , , and . American Journal of Epidemiology, 166 (7): 817--23 (October 2007)PMID: 17615088.Delivering a safe and effective strain-specific vaccine to control an epidemic of group B meningococcal disease, , , , and . The New Zealand Medical Journal, 122 (1291): 48--59 (2009)PMID: 19322255.The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic, , , , , , , , , and . The New Zealand Medical Journal, 117 (1200): U1015 (August 2004)PMID: 15475985.Immunogenicity and tolerability in infants of a New Zealand epidemic strain meningococcal B outer membrane vesicle vaccine, , , , , , , , , and . The Pediatric Infectious Disease Journal, 28 (5): 385--390 (May 2009)PMID: 19384263.